EMIS Group (AIM: EMIS)

Last close As at 29/02/2024

GBP19.20

0.00 (0.00%)

Market capitalisation

GBP1,232m

EMIS is a clinical software supplier to the primary, community and acute care markets in the UK and provides software to the community pharmacy market. Its Patient business provides medical and wellbeing information as well as transactional services to patients.

Latest Insights

View More

TMT | Flash note

EMIS Group — CMA provisionally clears takeover of EMIS

TMT | Update

EMIS Group — FY22 results in line

Sector

TMT

Balance Sheet

Forecast net debt (£m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (0.6) 32.2 3.3
Relative 3.7 40.4 1.3
52 week high/low 1934.0p/1310.0p

Financials

Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX) and Treatt (TET). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via website

Y/E Dec Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2021A 168.2 54.7 43.5 55.0 34.9 24.2
2022A 175.4 59.4 48.1 60.9 31.5 24.8
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Thematics

thematic

TMT

MediaWatch – Rinse and repeat

thematic

TMT

MediaWatch – Still waiting…

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free